Cargando…

Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease

Missense variants in leucine-rich repeat kinase 2 (LRRK2) lead to familial and sporadic Parkinson’s disease (PD). The pathological features of PD patients with LRRK2 variants differ. Here, we report an autopsy case harboring the LRRK2 G2385R, a risk variant for PD occurring mainly in Asian populatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Tezuka, Toshiki, Taniguchi, Daisuke, Sano, Mariko, Shimada, Tomoyo, Oji, Yutaka, Tsunemi, Taiji, Ikeda, Aya, Li, Yuanzhe, Yoshino, Hiroyo, Ogata, Jun, Shiba-Fukushima, Kahori, Funayama, Manabu, Nishioka, Kenya, Imai, Yuzuru, Hattori, Nobutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355991/
https://www.ncbi.nlm.nih.gov/pubmed/35931783
http://dx.doi.org/10.1038/s41531-022-00367-y
_version_ 1784763418319781888
author Tezuka, Toshiki
Taniguchi, Daisuke
Sano, Mariko
Shimada, Tomoyo
Oji, Yutaka
Tsunemi, Taiji
Ikeda, Aya
Li, Yuanzhe
Yoshino, Hiroyo
Ogata, Jun
Shiba-Fukushima, Kahori
Funayama, Manabu
Nishioka, Kenya
Imai, Yuzuru
Hattori, Nobutaka
author_facet Tezuka, Toshiki
Taniguchi, Daisuke
Sano, Mariko
Shimada, Tomoyo
Oji, Yutaka
Tsunemi, Taiji
Ikeda, Aya
Li, Yuanzhe
Yoshino, Hiroyo
Ogata, Jun
Shiba-Fukushima, Kahori
Funayama, Manabu
Nishioka, Kenya
Imai, Yuzuru
Hattori, Nobutaka
author_sort Tezuka, Toshiki
collection PubMed
description Missense variants in leucine-rich repeat kinase 2 (LRRK2) lead to familial and sporadic Parkinson’s disease (PD). The pathological features of PD patients with LRRK2 variants differ. Here, we report an autopsy case harboring the LRRK2 G2385R, a risk variant for PD occurring mainly in Asian populations. The patient exhibited levodopa-responsive parkinsonism at the early stage and visual hallucinations at the advanced stage. The pathological study revealed diffuse Lewy bodies with neurofibrillary tangles, amyloid plaques, and mild signs of neuroinflammation. Biochemically, detergent-insoluble phospho-α-synuclein was accumulated in the frontal, temporal, entorhinal cortexes, and putamen, consistent with the pathological observations. Elevated phosphorylation of Rab10, a substrate of LRRK2, was also prominent in various brain regions. In conclusion, G2385R appears to increase LRRK2 kinase activity in the human brain, inducing a deleterious brain environment that causes Lewy body pathology.
format Online
Article
Text
id pubmed-9355991
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-93559912022-08-07 Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease Tezuka, Toshiki Taniguchi, Daisuke Sano, Mariko Shimada, Tomoyo Oji, Yutaka Tsunemi, Taiji Ikeda, Aya Li, Yuanzhe Yoshino, Hiroyo Ogata, Jun Shiba-Fukushima, Kahori Funayama, Manabu Nishioka, Kenya Imai, Yuzuru Hattori, Nobutaka NPJ Parkinsons Dis Case Report Missense variants in leucine-rich repeat kinase 2 (LRRK2) lead to familial and sporadic Parkinson’s disease (PD). The pathological features of PD patients with LRRK2 variants differ. Here, we report an autopsy case harboring the LRRK2 G2385R, a risk variant for PD occurring mainly in Asian populations. The patient exhibited levodopa-responsive parkinsonism at the early stage and visual hallucinations at the advanced stage. The pathological study revealed diffuse Lewy bodies with neurofibrillary tangles, amyloid plaques, and mild signs of neuroinflammation. Biochemically, detergent-insoluble phospho-α-synuclein was accumulated in the frontal, temporal, entorhinal cortexes, and putamen, consistent with the pathological observations. Elevated phosphorylation of Rab10, a substrate of LRRK2, was also prominent in various brain regions. In conclusion, G2385R appears to increase LRRK2 kinase activity in the human brain, inducing a deleterious brain environment that causes Lewy body pathology. Nature Publishing Group UK 2022-08-05 /pmc/articles/PMC9355991/ /pubmed/35931783 http://dx.doi.org/10.1038/s41531-022-00367-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Case Report
Tezuka, Toshiki
Taniguchi, Daisuke
Sano, Mariko
Shimada, Tomoyo
Oji, Yutaka
Tsunemi, Taiji
Ikeda, Aya
Li, Yuanzhe
Yoshino, Hiroyo
Ogata, Jun
Shiba-Fukushima, Kahori
Funayama, Manabu
Nishioka, Kenya
Imai, Yuzuru
Hattori, Nobutaka
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
title Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
title_full Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
title_fullStr Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
title_full_unstemmed Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
title_short Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
title_sort pathophysiological evaluation of the lrrk2 g2385r risk variant for parkinson’s disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355991/
https://www.ncbi.nlm.nih.gov/pubmed/35931783
http://dx.doi.org/10.1038/s41531-022-00367-y
work_keys_str_mv AT tezukatoshiki pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease
AT taniguchidaisuke pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease
AT sanomariko pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease
AT shimadatomoyo pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease
AT ojiyutaka pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease
AT tsunemitaiji pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease
AT ikedaaya pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease
AT liyuanzhe pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease
AT yoshinohiroyo pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease
AT ogatajun pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease
AT shibafukushimakahori pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease
AT funayamamanabu pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease
AT nishiokakenya pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease
AT imaiyuzuru pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease
AT hattorinobutaka pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease